2Balkwili F,Mantovani A,Inflammation and cancer:back to yirchow?[J].Lancet,2001,357(9255):539-545.
3Mantovani A.Effects on in vitro tumor growth of routine maerophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity[J].Int J Cancer,1978,22(6):741-746.
4Dvorak HF.Tumors:wounds that do not heal.Similarities between tumor stroma generation and wound heMing[J].N EngI J Med,1986,315(26):1650-1659.
7Coussens LM,Tinkle CL,Hanahan D,et al.MMP-9 supplied by bone marrow-derived cells contributes to carcinogenesis[J].Cell,2000,103(3):481-490.
8Chen JJ,Lin YC,Yao PL.Tumor-associated macrophages:the double-edged sword in cancer progression[J].J Clin Oncol,2005,23(5):953-964
9Leek RD,Harris AL.Tumor-associated macrophages in breast cancer[J].J Mammary Gland Biol Neuplasia,2002,7(2):177-189.
10Nakayama Y,Nagashlma N,Minagawa N,et al.Relationships between lumor-associated macrophages and clinicopathological factors in patients with colorectal tauter[J].Anticancer Res,2002,229(6C):4291-4296.
3Dong Y, Tang L, Letterio JJ, et al. The Smad3 protein is involvedin TGF--βinhibition of class Ⅱ transactivator and class Ⅱ MHC expression[J].J Immunol, 2001, 167(1):311-319.
4Tuxhom JA, McAlhany SJ,Yang F,et al.Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactiv stroma xenograft model[J].Cancer Res,2002,62(21):6021-025.
5Li C, Guo B, Bemabeu C, et al. Angiogenesis in breast cancer:the role of transforming growth factor beta and CD105[J]. Microsc Res Tech, 2001,52(4):437-449.
6Comijn J, Berx G, Vermassen P, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion[J]. Mol Cell, 2001, 7(6):1267-1278.
7Muraoka RS, Dumont N, Ritter CA, et al. Blockade of TGF-be-ta inhibits mammary tumor cell viability, migration, and metastases[J].J CAin Invest, 2002, 109(12):1551-1559.
8del Re E, Babitt JL, Pirani A, et al. In the absence of type Ⅲ receptor, the transforming growth factor (TGF)-beta type Ⅱ-B receptor requires the type Ⅰ receptor to bind TGF-beta2 [J]. J Biol Chem, 2004, 279(21):22765-22772.
9Suzuki H, Yagi K, Kondo M, et al. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding dements [J]. Oncogene, 2004, 23 (29):5068-5076.
10Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nudeus[J]. Cell, 2003,113(14):685-670.
3Dong C.Th17 cells in development:an updated view of their molecular identity and genetic programming.Nat Rev Immunol,2008,8(5):337-348.
4Stumhofer J S,Laurence A.Interleukin negatively regulates the development of interleukin producing T helper ceils during chronic inflammation of the central nervous system.Nat Immunol,2006,7(9):937-945.
5Infante Duarte C,Horton H F,Byrne M C,et al.Microbial lipopep tides induce the production of IL-17 in Th cell.J Immunol,2000,165 (11):6107-6110.
6Dunn G P,Bruce A T,Ikeda H,et al.Cancer immunoediting: from immunosurveillance to tumor escape.Nat Immunol,2002, 3(11):991-998.
7Colotta F,Allavena P,Sica A,et al.Cancer-related inflammation,the seventh hallmark of cancer:links to genetic instability[J].Carcinogenesis,2009,30(7):1073-1081.
8Okumura T,Ericksen RE,Takaishi S,et al.K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation,an altered microenvironment,and progression to intraepithelial neoplasia[J].Cancer Res,2010,70(21):8435.
9Yin Y,Grabowska AM,Clarke PA,et al.Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer:links to soluble HB-EGF,gastrin and matrix metalloproteinase-7[J].Gut,2010,59(8):1037-1045.
10Giannice R,Erreni M,Allavena P,et al.Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor(MIF)mRNA and Vascular Endothelial Growth Factor(VEGF)mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium:apilot study[J].Cytokine,2013,64(2):509-515.
